2022
Therapeutic potential of dehydroepiandrosterone for Parkinson's disease: scoping review protocol
Abstract: Background: Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigrostriatal dopaminergic neurons. Its treatment is symptomatic and shows limited efficacy. Dehydroepiandrosterone (DHEA) is a hormone produced in the brain. Several studies have reported beneficial effects of the steroid in experimental models of PD and various human diseases, but its potential for PD is inconclusive. Therefore, it is necessary to evaluate current evidence to determine the therapeutic …
Search citation statements
Paper Sections
Select...
3
0
0
0
Citation Types
0
1
0
0
Year Published
2022
2023
Publication Types
Select...
3
Relationship
0
3
Authors
Journals
Cited by 3 publications
(1 citation statement)
References 41 publications
0
1
0
0
“…This methodology is based on a preceding protocol, 22 but it is not an update of any previous review. After elaborating on the research question, we used an online tool to define the most appropriate type of review, as previously reported, 23 which was scoping review (https:// whatreviewisrightforyou.knowledgetranslation.net/map/ results?id=5413&code=GAkWQRoevx).…”
Section: Protocol Developmentmentioning
confidence: 99%
“…This methodology is based on a preceding protocol, 22 but it is not an update of any previous review. After elaborating on the research question, we used an online tool to define the most appropriate type of review, as previously reported, 23 which was scoping review (https:// whatreviewisrightforyou.knowledgetranslation.net/map/ results?id=5413&code=GAkWQRoevx).…”
Section: Protocol Developmentmentioning
confidence: 99%
